Event JSON
{
"id": "7d5a2b10c7e8144a72daa6fefde4e611a982d30080ce58c62a450493e09552c5",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1735059316,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/salesforce-stokes-veeva-fight-snagging-153210048.html"
],
[
"subject",
"Salesforce Stokes Veeva Fight by Snagging Drug Customers"
],
[
"published_at",
"1735054330"
],
[
"image",
"https://s.yimg.com/ny/api/res/1.2/yz.tDxJmViP2HKyTEelzPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_technology_68/83f9e10276e07859261e7a02019c2dbd"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://s.yimg.com/ny/api/res/1.2/yz.tDxJmViP2HKyTEelzPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_technology_68/83f9e10276e07859261e7a02019c2dbd"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"Salesforce is launching a life sciences product to compete with Veeva, a well-entrenched incumbent with over 80% market share. Over 40 customers, including a top three global pharma leader, have signed up for Salesforce's product, with some switching from Veeva. Veeva's shares fell 4.7% on the news, while Salesforce's shares were unchanged."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://s.yimg.com/ny/api/res/1.2/yz.tDxJmViP2HKyTEelzPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_technology_68/83f9e10276e07859261e7a02019c2dbd\n\nhttps://finance.yahoo.com/news/salesforce-stokes-veeva-fight-snagging-153210048.html",
"sig": "e89ecd6a8fa3055ef1d2b1bb9ac32a4d0635575fffa54215bdbb80c7ed1a477e2142b79fbcb6238de696a829cfd605d40ad57adb58fc3ae908c7afa82bd67df0"
}